Real-time investigation of human topoisomerase I reaction kinetics using an optical sensor: a fast method for drug screening and determination of active enzyme concentrations.

Human DNA topoisomerase I (hTopI) is a nuclear enzyme that catalyzes relaxation of super helical tension that arises in the genome during essential DNA metabolic processes. This is accomplished through a common reaction mechanism shared among the type IB topoisomerase enzymes, including eukaryotic and poxvirus topoisomerase I. The mechanism of hTopI is specifically targeted in cancer treatment using camptothecin derivatives. These drugs convert the hTopI activity into a cellular poison, and hence the cytotoxic effects of camptothecin derivatives correlate with the hTopI activity. Therefore, fast and reliable techniques for high throughput measurements of hTopI activity are of high clinical interest. Here we demonstrate potential applications of a fluorophore-quencher based DNA sensor designed for measurement of hTopI cleavage-ligation activities, which are the catalytic steps affected by camptothecin. The kinetic analysis of the hTopI reaction with the DNA sensor exhibits a characteristic burst profile. This is the result of a two-step ping-pong reaction mechanism, where a fast first reaction, the one creating the signal, is followed by a slower second reaction necessary for completion of the catalytic cycle. Hence, the burst profile holds information about two reactions in the enzymatic mechanism. Moreover, it allows the amount of active enzyme in the reaction to be determined. The presented results pave the way for future high throughput drug screening and the potential of measuring active hTopI concentrations in clinical samples for individualized treatment.

[1]  E. L. Kristoffersen,et al.  Molecular Beacon Enables Combination of Highly Processive and Highly Sensitive Rolling Circle Amplification Readouts for Detection of DNA-Modifying Enzymes , 2015 .

[2]  J. Lupski,et al.  Real-time detection of TDP1 activity using a fluorophore-quencher coupled DNA-biosensor. , 2013, Biosensors & bioelectronics.

[3]  S. H. Lee,et al.  A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer , 2013, Cancer Chemotherapy and Pharmacology.

[4]  T. Hsieh,et al.  New mechanistic and functional insights into DNA topoisomerases. , 2013, Annual review of biochemistry.

[5]  Yi-Ping Ho,et al.  DNA-Based Sensor for Real-Time Measurement of the Enzymatic Activity of Human Topoisomerase I , 2013, Sensors.

[6]  Baek Kim,et al.  Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase. , 2012, Virology.

[7]  Cheng-Yang Huang,et al.  Characterization of Flavonol Inhibition of DnaB Helicase: Real-Time Monitoring, Structural Modeling, and Proposed Mechanism , 2012, Journal of biomedicine & biotechnology.

[8]  Chengxiao Zhang,et al.  Sensitive detection of endonuclease activity and inhibition using gold nanorods. , 2012, Biosensors & bioelectronics.

[9]  N. Osheroff,et al.  DNA cleavage and opening reactions of human topoisomerase IIα are regulated via Mg2+-mediated dynamic bending of gate-DNA , 2012, Proceedings of the National Academy of Sciences.

[10]  D. Spiegelman,et al.  Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803 , 2011, Clinical Cancer Research.

[11]  H. Roder,et al.  Retroviral Integrases Promote Fraying of Viral DNA Ends* , 2011, The Journal of Biological Chemistry.

[12]  A. Bogdanov,et al.  Hairpin-like fluorescent probe for imaging of NF-κB transcription factor activity. , 2011, Bioconjugate chemistry.

[13]  Ashley H. Hardin,et al.  Direct measurement of DNA bending by type IIA topoisomerases: implications for non-equilibrium topology simplification , 2011, Nucleic acids research.

[14]  M. Lisby,et al.  A Flp-nick system to study repair of a single protein-bound nick in vivo , 2009, Nature Methods.

[15]  Felicie F. Andersen,et al.  Resolution of Holliday junction substrates by human topoisomerase I. , 2007, Journal of molecular biology.

[16]  Y. Pommier,et al.  Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes* , 2003, Journal of Biological Chemistry.

[17]  A. Marangoni Enzyme Kinetics , 2019, Fundamentals of Biofuels Engineering and Technology.

[18]  JAMES C. Wang,et al.  Cellular roles of DNA topoisomerases: a molecular perspective , 2002, Nature Reviews Molecular Cell Biology.

[19]  L. Saltz,et al.  Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. , 2000, The New England journal of medicine.

[20]  F. Boege,et al.  Camptothecins inhibit the utilization of hydrogen peroxide in the ligation step of topoisomerase I catalysis. , 1998, Biochemistry.

[21]  W G Hol,et al.  A model for the mechanism of human topoisomerase I. , 1998, Science.

[22]  M. Eigen,et al.  Real-time enzyme kinetics monitored by dual-color fluorescence cross-correlation spectroscopy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Eigen,et al.  Rapid assay processing by integration of dual-color fluorescence cross-correlation spectroscopy: high throughput screening for enzyme activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Straub,et al.  Separation and functional analysis of eukaryotic DNA topoisomerases by chromatography and electrophoresis. , 1996, Journal of chromatography. B, Biomedical applications.

[25]  A. Mildvan,et al.  Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions. , 1994, Biochemistry.

[26]  O. Westergaard,et al.  Characterization of intra- and intermolecular DNA ligation mediated by eukaryotic topoisomerase I. Role of bipartite DNA interaction in the ligation process. , 1994, The Journal of biological chemistry.

[27]  A. Andersen,et al.  Eukaryotic topoisomerase I-mediated cleavage requires bipartite DNA interaction. Cleavage of DNA substrates containing strand interruptions implicates a role for topoisomerase I in illegitimate recombination. , 1993, The Journal of biological chemistry.

[28]  S. Shuman,et al.  Specific DNA cleavage and binding by vaccinia virus DNA topoisomerase I. , 1990, The Journal of biological chemistry.

[29]  J. Wang,et al.  Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. , 1989, Cancer research.

[30]  L. Liu,et al.  Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. , 1989, Cancer research.

[31]  J. Wang,et al.  Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[33]  A. Andersen,et al.  Topoisomerase I has a strong binding preference for a conserved hexadecameric sequence in the promoter region of the rRNA gene from Tetrahymena pyriformis. , 1985, Nucleic acids research.

[34]  Y. Ho,et al.  Quantum dot based DNA nanosensors for amplification-free detection of human topoisomerase I , 2014 .

[35]  J. Champoux DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.

[36]  R. Ozols Optimum chemotherapy for ovarian cancer. , 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[37]  A. Fersht Enzyme structure and mechanism , 1977 .